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ABSTRACT
Penicillin-resistant Streptococcus pneumoniae isolates (n = 76) from clinical samples of patients admitted to
Hacettepe University Hospital between January 1997 and December 2001 were included in the study.
MICs of penicillin G, erythromycin A, clindamycin, cefaclor, cefotaxime, vancomycin, chloramphenicol,
tetracycline, ciprofloxacin and rifampicin were determined by agar dilution. The isolates were
serogrouped on the basis of the Neufeld Quellung reaction and were typed by BOX-PCR. Genetic
polymorphism of the penicillin resistance genes pbp2b and pbp2x was investigated by restriction fragment
length polymorphism (RFLP) analysis. Of the 76 isolates tested, 64 (84.2%) showed intermediate
resistance to penicillin, while 12 (15.8%) were resistant to higher levels of penicillin (MIC ‡ 2 mg/L). The
resistance patterns of the isolates revealed six different resistance profiles. There were 22 different
serotypes, with c. 55% of the isolates belonging to serotypes 23B, 19A, 19F, 14, 6 A and 9V. Five distinct
patterns for pbp2b and 12 distinct patterns for pbp2x were obtained by RFLP analysis of penicillin-binding
protein genes. The combination of these patterns allowed isolates to be classified into 22 fingerprint
subgroups. BOX-PCR analysis showed that the isolates fell into 14 distinct BOX genotypes, with 33
subtypes. Serotype 9V isolates with pbp genotype 2-6 and BOX-PCR type 4, 4.1 or 4.2 were related to the
pandemic clone Spain9V-3. No relatedness to other international clones was detected among the other
study strains, but genetic relatedness was observed among some of the serotype 19A and 23B isolates.
Overall, the results demonstrated that most of the penicillin-resistant pneumococcal isolates in Turkey,
other than those belonging to serotypes 9V, 19A and 23B, were derived from several independent clones,
possibly resulting from multiple importation of strains originating from outside the country. Differences
in pbp patterns, serotypes and resistance profiles among isolates that showed similar BOX-PCR patterns
supported the hypothesis that horizontal transfer of capsular genes, pbp genes and other genetic
determinants between S. pneumoniae and viridans group streptococci may have occurred.
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INTRODUCTION
Streptococcus pneumoniae remains an important
human pathogen associated with significant mor-
bidity and mortality [1, 2]. The prevalence of
penicillin resistance among pneumococci is
increasing alarmingly worldwide, and interna-
tional spread of a restricted number of multire-
sistant pneumococcal clones has contributed
significantly to this increase [2–4].
The standard method of typing pneumococci is
serotyping, and this has been used to follow the
spread of penicillin-resistant S. pneumoniae. The
value of this approach is limited, since many
resistant isolates fall into a small number of
serotypes [2]. Alternative approaches such as
BOX-PCR (i.e., PCR involving pneumococcal
repetitive sequences), pulsed-field gel electrophor-
esis, restriction fragment length polymorphism
analysis of penicillin-binding protein (PBP) genes
and multilocus sequence typing have been shown
to be sensitive methods [4–7]. PBP genes of
resistant pneumococci show a mosaic structure,
and the different mosaic PBP genes can be used for
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epidemiological purposes by analysing the pat-
terns of PBP fingerprints [6]. It has been shown
that the BOX-PCR assay, which targets a dispersed
repetitive motif in the genome of S. pneumoniae,
has equal or even greater resolving power than
any of the other more laborious, complex and
expensive DNA typing strategies [5].
In Turkey, the prevalence of penicillin-resistant
pneumococci (MIC ‡ 0.1 mg/L) varies over the
range 32–43.5%, with high-level penicillin-resist-
ant isolates occurring at a frequency of 3–7% in
certain centres [8–10]. This paper describes a
molecular epidemiological study that was under-
taken to identify the reasons for the high preval-
ence of penicillin-resistant pneumococci in our
centre.
MATERIALS AND METHODS
Pneumococcal strains
In total, 76 penicillin-resistant S. pneumoniae isolates were
chosen for molecular investigation from 179 S. pneumoniae
strains isolated from clinical samples of patients admitted to
Hacettepe University Hospital, Ankara during the period
January 1997 to December 2001. A single pneumococcal
isolate/patient/infection was analysed. S. pneumoniae species
identification was on the basis of optochin susceptibility and
bile solubility as described previously [8]. The pneumococci
were collected from sputum (57.9%), bronchoalveolar lavage
(14.6%), throat swab (10.6%), blood (3.9%), eye swab (3.9%),
pus (2.6%), cerebrospinal fluid (2.6%), trans-tracheal aspirate
(2.6%) and pleural fluid (1.3%). Isolates denoted with the
capital letters B and P were from children, and those denoted
with C were from adult patients.
Susceptibility testing
MICs were determined by the agar dilution method [8].
Breakpoints for intermediate and high-level penicillin resist-
ance were according to National Committee for Clinical
Laboratory Standards guidelines [11]. The antimicrobial agents
tested were penicillin G, erythromycin A, clindamycin, cefac-
lor, cefotaxime, vancomycin, chloramphenicol, tetracycline,
ciprofloxacin and rifampicin. S. pneumoniae strain ATCC 49619
was included in each batch of isolates tested as a quality
control.
Macrolide–lincosamide–streptograminB (MLSB) resistance
phenotypes were determined by a double-disk diffusion
technique with erythromycin and clindamycin disks according
to National Committee for Clinical Laboratory Standards
guidelines [11]. The MLSB phenotype was defined as resistance
to erythromycin and clindamycin, while an isolate with the M
phenotype was resistant to erythromycin alone.
Serotyping
Pneumococci were serotyped on the basis of the Neufeld
Quellung reaction at the Centers for Disease Control (Atlanta,
GA, USA).
DNA isolation
S. pneumoniae isolates were cultivated on sheep blood (5%
v/v) agar in 5–10% CO2 at 37C overnight. Colonies were then
emulsified in 100 lL TE buffer (10 mM Tris, 1 mM EDTA,
pH 7.5), and DNA was extracted by boiling [12] with an
additional freeze–thaw step. DNA extracts were kept at ) 20C
until used for PCR amplification.
BOX-PCR
Typing of pneumococci by BOX-PCR was performed as
described by Van Belkum et al. [5]. Briefly, pneumococcal
DNA was amplified by PCR with primer BOX-A. Amplified
products were separated on an agarose 1.5% w/v gel. BOX-
PCR patterns showing a single band difference were defined
as non-identical types (i.e., 1–12). Identical banding patterns
varying in the intensity of one or more bands were defined as
subtypes (i.e., 1, 1.1, 1.2, etc.).
PBP genotyping
Genetic polymorphism of the penicillin resistance genes pbp2b
and pbp2x was investigated by restriction fragment length
polymorphism analysis as described by Coffey et al. [6].
Following PCR amplification of the PBP genes, the amplifica-
tion products were digested with restriction endonuclease
HinfI at 37C for 20 h. Digested DNA was separated by
electrophoresis in agarose 1.8% w/v gels. The different PBP
genotypes were identified by a number code.
BOX-PCR and pbp2b and pbp2x patterns of the major
international antimicrobial resistant clones of S. pneumoniae,
as defined by the Pneumococcal Molecular Epidemiology
Network, were also determined by the same methods to
compare the genotypes and to determine any possible clonal
relationship between the Turkish isolates and these interna-
tional clones. The 16 standard pneumococcal clones and their
ATCC accession numbers were as follows: Spain23F-1 (ATCC
700669), Spain6B-2 (ATCC 700670), Spain9V-3 (ATCC 700671),
Tennessee23F-4 (ATCC 51916), Spain14-5 (ATCC 700902),
Hungary19A-6 (ATCC 700673), South Africa19A-7 (ATCC
700674), South Africa6B-8 (ATCC 700675), England14-9 (ATCC
700676), CSR14-10 (ATCC 700677), CSR19A-11 (ATCC 700678),
Finland6B-12 (ATCC 700903), South Africa19A-13 (ATCC
700904), Taiwan19F-14 (ATCC 700905), Taiwan23F-15 (ATCC
700906) and Poland23F-16.
Computer analysis of BOX profiles
Genetic relatedness of the 76 study isolates and the 16 standard
clones was determined by SPSS v.10.0 software (SPSS Inc.,
Chicago, IL, USA). Between-group linkage was used as a
cluster method and squared Euclidean distance as a measure.
RESULTS
In total, 76 penicillin-non-susceptible pneumococ-
cal strains were analysed by resistance profiles,
serotyping, pbp2b and pbp2x genotyping, and
BOX-PCR. Of these, 64 (84.2%) showed interme-
diate resistance to penicillin, while 12 (15.8%)
were resistant to higher levels of penicillin (MICs
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‡ 2 mg/L). Resistance to cefaclor, cefotaxime,
erythromycin, clindamycin and chloramphenicol
was significantly higher in penicillin-resistant
isolates than in penicillin-intermediate isolates
(Table 1). One-third of penicillin-resistant isolates
were also resistant to cefotaxime. The overall
resistance to erythromycin was 23.6% and that to
clindamycin was 21%. Phenotyping of erythro-
mycin-resistant isolates (n = 18) revealed that 11
(61.1%) had the cMLSB phenotype, five (27.8%)
had the iMLSB phenotype, and two (11.1%) had
the M phenotype. About 40% of the penicillin-
resistant isolates were multiresistant, i.e., resistant
to two or more different groups of antibiotics. Six
different resistance profiles, ranging from resist-
ance to b-lactams only to multidrug resistance
against b-lactams, erythromycin, tetracycline and
chloramphenicol, were observed. None of the
isolates was resistant to vancomycin. One isolate
was resistant to rifampicin and one to ciprofloxa-
cin.
Serotyping revealed 20 different serotypes,
namely, serotypes 23B (10 isolates), 19A (8), 19F
(8), 14 (7), 9V (6), 6A (5), 23F (4), 9A (2), 4 (2), 11A
(2), 15B (2), 1 (2), 3 (1) 6B (1), 7 (1), 9N (1), 16F (1),
10 (1), 31 (1), and 33A (1), in order of decreasing
frequency. About 55% of the isolates belonged to
serotypes 23B, 19A, 19F, 14, 9V and 6A. Ten
(11.6%) isolates could not be serotyped, although
proven to be S. pneumoniae by bile solubility. One
of these non-typeable isolates was from a cere-
brospinal fluid sample, and one from a pleural
fluid sample, while the others were from the
respiratory tract.
Genetic heterogeneity in the penicillin resist-
ance genes was investigated by PBP genotyping
of the pbp2b and pbp2x genes. Five distinct
patterns were obtained for pbp2b and 12 distinct
patterns for pbp2x. By combining these patterns,
22 fingerprint subgroups (namely 1-1 to 1-12, 2-1,
2-3, 2-6, 2-8, 3-1, 3-5, 4-1, 4-3, 4-5 and 5-11) could
be defined. When the MIC values were evaluated
in relation to the PBP variations, it was seen that
there was more variation in pbp2x genes than in
pbp2b genes, which seemed to be associated with
the low-level penicillin resistance expressed in
those isolates.
BOX-PCR analysis divided the isolates into 14
distinct BOX genotypes, with 33 subtypes. When
the BOX patterns were evaluated together with
serotypes and PBP types, two isolates (B8 and
B78) were identical to the Spain9V-3 clone, while
four other isolates (C80, B81, C78 and B55) were
related closely to the same clone. No relatedness
to the international clones was detected among
the other isolates in the study.
Serotype 23B isolates B64, B66, B60 and B62
were identical to each other when BOX-PCR
types, PBP types and serotypes were taken into
consideration.
Isolates P11, P37, B41, B80, B85, B71 and B73
were apparently identical by BOX-PCR patterns,
but only B71 and B73 were identical both by
serotype (19A) and PBP type, while P11 had the
same PBP pattern, but belonged to serotype 6A,
indicating possible horizontal transfer of capsular
genes.
There was also a group of isolates with
identical BOX patterns, but with a high degree
of heterogeneity in terms of PBP types and
serotypes (i.e., isolates C40, C79, B11, P66, C35,
P20, P63, P4, P8, B74, B77 and B53). Some of
these isolates seemed to be related genetically,
since they had the same serotype and pbp2b and/
or pbp2x types.
Table 1. Antibiotic susceptibilities of 76 S. pneumoniae
isolates (64 isolates showing intermediate (I) resistance to
penicillin, and 12 strains showing resistance (R) to peni-
cillin) subdivided according to their level of penicillin
resistance
Antibiotic
MIC range
(mg/L)
MIC50
(mg/L)
MIC90
(mg/L) % Resistance
Penicillin
I 0.125–1 0.25 1 0
R 2–8 2 4 100.0
Cefaclor
I 0.125–4 1 4 23.4
R 4–> 32 8 > 32 100.0
Cefotaxime
I £ 0.06–0.5 0.125 0.25 0
R 0.5–2 0.5 4 33.3
Erythromycin
I £ 0.06–> 32 0.125 8 23.4
R £ 0.06–16 0.125 4 25.0
Clindamycin
I £ 0.06–> 32 0.125 2 20.3
R £ 0.06–> 32 0.125 > 32 25.0
Chloramphenicol
I 0.25–8 2 4 3.1
R 1–16 2 8 16.7
Tetracycline
I £ 0.06–> 32 0.25 16 28.1
R 0.25–16 0.5 8 16.7
Vancomycin
I £ 0.06–0.5 0.25 0.5 0
R 0.25–0.5 0.5 0.5 0
Ciprofloxacin
I 0.5–> 8 1 2 1.5
R 0.5–1 1 1 0
Rifampicin
I £ 0.03–4 0.03 0.03 1.5
R £ 0.03–0.125 0.03 0.06 0
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DISCUSSION
Resistance to penicillin is increasing rapidly
worldwide among strains of S. pneumoniae.
Molecular analysis has shown that a specific
strain of penicillin-resistant pneumococcus may
spread from country to country, and even
between continents. The prevalence of pneumo-
cocci with penicillin MICs > 0.1 mg/L is 32–44%
in Turkey [8–10]. Although this is not a nation-
wide study on the prevalence and molecular
epidemiology of penicillin-resistant pneumococci
in Turkey, it reflects the overall picture, since the
isolates in the study were from patients admitted
to this centrally located reference hospital from
different parts of the country.
The presence of multiresistance in c. 40% of the
penicillin-resistant isolates has serious therapeu-
tic implications. b-Lactams and macrolides are
obtained frequently ‘over-the-counter’ in Turkey,
favouring rapid selection of pneumococci with
reduced susceptibility. Phenotypic characterisa-
tion of the macrolide-resistant pneumococci in
this study revealed that most expressed the
cMLSB phenotype, a result consistent with find-
ings in many other European countries [13].
Acquisition and spread of b-lactam resistance in
pneumococci are complex processes. Close con-
tact among children and frequent antibiotic treat-
ment favour the selection and spread of resistant
pneumococci. Most of the S. pneumoniae isolates
tested in this study were from children who were
receiving antibiotics because of frequent respirat-
ory tract infections.
Some genetic (PBP pattern) and phenotypic
(serotype and resistance profile) differences were
observed among isolates with similar BOX-PCR
patterns, which might be attributed to the hori-
zontal transfer of capsular genes, PBP genes and
other genetic determinants between these isolates
and other pneumococcal strains or viridans strep-
tococci. Serotyping revealed that 55% of the
isolates belonged to serotypes 23B, 19A, 19F, 14,
9V and 6A, which are covered in the seven-valent
conjugate vaccine. These data correspond largely
to earlier findings in other European countries,
the USA and the Far East, in which these
serogroups also contributed significantly to the
prevalence of penicillin-resistant pneumococci
[14–20]. About 11% of the isolates could not be
serotyped with the available typing system.
Since about 82% of these isolates were from the
respiratory tract, these may be contaminants
rather than true pathogens.
The discriminatory power of serotyping is
considered to be poor, since different genotypes
may express the same phenotypic characteristics
and, as S. pneumoniae is a naturally transformable
species, frequent exchange of capsular genes may
occur [6, 21, 22]. This was confirmed in the present
study by molecular typing, which demonstrated
that isolates from most serotypes were genetically
heterogeneous, and that many clones were detec-
ted during the study period. However, penicillin-
resistant pneumococci of serotypes 23B and 9V
appeared to be more clonal. Further evaluation of
these isolates revealed that the serotype 9V iso-
lates with PBP genotype 2-6 and BOX-PCR type 4,
4.1 or 4.2 were related to the pandemic clone
Spain9V-3 [4], providing further evidence that
antibiotic-resistant isolates expand clonally be-
cause of an evolutionary advantage. Thus, the
Spain9V-3 clone was identified first in Spain [6]
and France [23], and then subsequently in the UK,
Italy, Germany, the USA and the Far East [6, 17, 18,
24, 25]. Similarly, worldwide spread of the
Spain23F-1 clone from Spain to the USA was
reported by Munoz et al. [3], and then subse-
quently to various regions of the world, including
the UK, Bulgaria, Germany, France, South Africa
and Portugal [6, 14, 18, 23, 26, 27]. This is the first
report from Turkey on the possible presence of the
Spain9V-3 pandemic clone in our country.
Overall, these results suggest that most peni-
cillin-resistant pneumococcal isolates in Turkey,
other than serotypes 9V and 23B, were derived
from several independent clones. It is possible
that the diversity of resistant genotypes detected
in this study may be associated with multiple
importation of strains originating from outside
the country, particularly as Turkey is one of the
main transit countries between East and West.
Although some of the serogroup 23 and 9 isolates
may have originated from a common ancestor,
multiplication of these possible clones does not
seem to be the only process explaining penicillin-
resistant pneumococcal spread in our region.
However, in such a densely populated country,
it is always possible that particular multidrug-
resistant pneumococcal clones may become suc-
cessful and disseminate widely throughout the
country.
Several isolates showed diversity among PBP
genes, indicating independent mutation of PBP
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genes, or horizontal transfer of PBP genes
between strains. The overall data were consistent
with the likelihood that all or most of the
penicillin-resistant isolates described here carried
mosaic pbp2b and pbp2x gene sequences that
originated from past recombination events with
other streptococcal species. It is well known that
strains with similar BOX profiles can be of
different serotype, PBP type and even pulsed-
field gel electrophoresis type. The heterogeneity
of PBP types in the same BOX clusters obtained in
this study could be attributed to this.
The increasing prevalence of penicillin and
multidrug-resistant pneumococci in Turkey
emphasises the importance of judicious use of
antibiotics and vaccination to prevent serious
pneumococcal infections in people at greater risk
for pneumococcal disease.
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